A study on Siddha trail drug Maha manjishtathi kashayam(INT)Chemparuthi poo ennai (EXT)and Aasanam in patients having Psoriasis

An open comparative clinical evalution on Thadippu perunoi (Psoriasis)with Siddha herbal formulation drug Maha manjishtathi kashayam(INT),Chemparuthi poo ennai (EXT)and Aasanam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013686

Enrollment

Registered

2018-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Thethru kuttam (Psoriasis)

Interventions

Intervention1: Maha Manjishtathi Kashayam: 30ml of Kashayam is administered twice a day for 48 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who are having classical symptoms of Psoriasis 2.Auspitz sign positive 3.Koebners phenomenon positive

Exclusion criteria

Exclusion criteria: 1.Patients of age below 18 and above 60 2.Patients having pustular Psoriasis 3.SLE 4.Leprosy 5.Pregnancy 6.Alcoholics 7.Prolonged NSAID intakers

Design outcomes

Primary

Measure	Time frame
outcome is reduction in scaling and erythematous patches which is assesssed by PASI ScoreTimepoint: nil	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr E Nandhini

Govt Siddha Medical College

spmhibiscus@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026